Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Logo of bmccancBioMed Central web sitethis articleSearchManuscript submissionRegistrationJournal front page
PMC full text:
Published online 2024 Apr 26. doi: 10.1186/s12885-024-12229-2

Fig. 1

An external file that holds a picture, illustration, etc.
Object name is 12885_2024_12229_Fig1_HTML.jpg

The low mRNA expressions of Dsg2 and Dsc2 were associated with progressionand poor prognosis by bioinformatics analysis. (A-D) The mRNA expressions of Dsg2 and Dsc2 were reduced in BC tissues from TCGA database (A, C) and TNMplot database (B, D). (E-F) The mRNA expressions of Dsg2 and Dsc2 were associated with molecular subtypes of BC from TCGA database. (G-J) The mRNA expression levels of Dsg2 and Dsc2 were negatively correlated with stage and nodal metastasis status of BC from TCGA database. (K-V) KM plotter analysis showed the low mRNA expressions of Dsg2 and Dsc2 were associated with poor overall survival whatever in all population or in molecular subtypes. (W-X) The mRNA expressions of Dsg2 and Dsc2 were positively correlated in normal breast tissues (W) and in BC tissues from the TNMplot data. *indicates P < 0.05

Images in this article

  • Fig. 1
  • Fig. 2
  • Fig. 3
  • Fig. 4
  • Fig. 5
  • Fig. 6
  • Fig. 7
  • Fig. 8
Click on the image to see a larger version.